Orion Market Research Pvt. Ltd. info@omrglobal.com +91 780-304-0404
Help Center
Careers
Contact

HPV Testing and Pap Test Market

HPV Testing and Pap Test Market Size, Share & Trends Analysis Report, By Product Type (Instruments, Assay Kits & Reagents, Consumables), By Technology (PCR-based Testing, Hybrid Capture Technology, Next-Generation Sequencing, Other Molecular Methods), By End User (Hospitals, Diagnostic Laboratories, Clinics & Gynecology Centers, Home-care / Self-sampling), Forecast Period (2026-2035)

Published: Jun 2026 | Report Code: OMR2029800 | Category : Medical Devices | Delivery Format: /

Industry Overview

The global HPV testing and Pap test market was valued at $2.8 billion in 2025 and is projected to reach $7.4 billion by 2035, growing at a CAGR of 10.2% during 2026 to 2035. The market is witnessing steady growth due to the increasing burden of cervical cancer and rising awareness regarding early detection and preventive screening programs. According to the World Health Organization (WHO), cervical cancer accounts for over 660,000 new cases annually, making it one of the leading causes of cancer-related deaths among women globally. WHO further states that nearly all cervical cancer cases are linked to persistent HPV infection, reinforcing the importance of regular screening through HPV testing and Pap tests. Additionally, WHO’s global elimination strategy aims to ensure 70% of women are screened by age 35 and again by 45, which is expected to significantly increase testing volumes.

The market is also supported by advancements in molecular diagnostics technologies, particularly PCR-based testing, which offers higher sensitivity compared to traditional cytology methods. Key end-use industries include hospitals, diagnostic laboratories, and specialized gynecology clinics, with the growing adoption of home-based self-sampling kits further expanding accessibility.

Market Dynamics

Driver: Rising Global Cervical Cancer Burden and Screening Initiatives

The growing prevalence of cervical cancer is a primary driver of the HPV testing and Pap test market. According to WHO, cervical cancer remains the fourth most common cancer in women, with a disproportionately high burden in low- and middle-income countries. WHO estimates that over 90% of cervical cancer deaths occur in developing regions, highlighting the urgent need for scalable screening solutions.

Government-led screening programs and global initiatives are significantly boosting market demand. For instance, WHO’s cervical cancer elimination initiative aims to vaccinate 90% of girls, screen 70% of women, and treat 90% of cases by 2030. These targets are encouraging healthcare systems to adopt HPV DNA testing as a primary screening method.

Companies are responding with strategic innovations. Between 2025 and 2026, major manufacturers have focused on automation, high-throughput systems, and self-sampling technologies to meet rising demand and improve accessibility. This trend is particularly prominent in emerging markets where healthcare infrastructure is expanding.

Challenge: High Cost and Limited Access in Developing Regions

Despite strong growth prospects, the market faces challenges related to high testing costs and limited access in resource-constrained regions. Advanced molecular diagnostics, such as PCR-based HPV testing, require specialized equipment and trained personnel, which can increase overall screening costs.

According to the OECD, disparities in healthcare infrastructure and diagnostic accessibility persist across regions, particularly in low-income countries where screening coverage remains below recommended levels. Additionally, supply chain disruptions and regulatory complexities can delay product approvals and market entry.

To address these challenges, companies are investing in cost-effective solutions such as portable diagnostic devices and self-sampling kits. Public-private partnerships are also emerging to improve screening accessibility, particularly in underserved populations.

Market Segmentation

  • Based on the product type, the market is segmented into instruments, assay kits & reagents, and consumables.
  • Based on the technology, the market is segmented into PCR-based testing, hybrid capture technology, next-generation sequencing, and other molecular methods.
  • Based on the end user, the market is segmented into hospitals, diagnostic laboratories, clinics & gynecology centers, and home-care / self-sampling.

Assay Kits & Reagents Segment Leads the Market

The Assay Kits & Reagents segment dominates the HPV testing and Pap test market due to its recurring demand and critical role in diagnostic workflows. These kits are widely used in PCR-based testing, offering high sensitivity and accuracy for HPV detection.

The increasing shift toward molecular diagnostics and HPV DNA testing has significantly boosted demand for assay kits. Between 2022 and 2026, leading companies have focused on expanding their reagent portfolios and improving assay efficiency to support high-throughput screening.

PCR-based Testing Segment to Record Strong Growth

The PCR-based testing segment is expected to witness the fastest growth due to its superior accuracy and ability to detect high-risk HPV strains at early stages. Technological advancements and increasing adoption of automated systems are driving segment growth.

Investments in molecular diagnostics infrastructure and rising preference for primary HPV screening over traditional cytology are further accelerating demand.

Regional Outlook

The global HPV testing and Pap test market is geographically segmented into North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa and Latin America).

United States Leads the Market

The United States dominates the market due to its strong healthcare infrastructure and widespread screening programs. According to the Centers for Disease Control and Prevention (CDC), cervical cancer screening rates in the U.S. remain high, supported by government initiatives and insurance coverage. Additionally, the U.S. Food and Drug Administration (FDA) continues to approve advanced HPV testing technologies, driving innovation and adoption.

India to Record Strong Growth

India is expected to witness significant growth due to increasing awareness and government-led screening programs. According to the WHO, India accounts for a substantial share of global cervical cancer cases, highlighting the need for improved screening coverage. Expanding healthcare infrastructure and rising adoption of cost-effective diagnostic solutions are supporting market growth.

Competitive Landscape

The HPV testing and Pap test market is moderately consolidated, with key players focusing on innovation, product development, and strategic collaborations. Leading companies such as Roche Diagnostics, Hologic Inc., QIAGEN N.V., BD (Becton Dickinson), and Abbott Laboratories are investing in advanced molecular diagnostics and expanding their global presence. These companies are leveraging automation, AI-driven diagnostics, and high-throughput systems to strengthen their market position.

Recent Developments

  • In October 2025, BD (Becton, Dickinson and Company) launched an IVDR-certified at-home HPV self-collection solution integrated with the BD COR™ System. This innovation simplifies sample collection and enables fully automated laboratory processing, expanding access to cervical cancer screening and supporting the shift toward HPV-based testing in the global HPV testing and Pap test market.
  • In December 2025, Abbott Laboratories highlighted advancements in its Alinity m HR HPV test, supporting primary HPV screening and self-collection options. The test enables detailed genotyping of high-risk HPV strains and expands access to screening through at-home collection kits, reinforcing the shift toward HPV-based screening and improving early detection in the HPV testing and Pap test market.

The Report Covers

  • Market value data analysis of 2025 and forecast to 2035.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global HPV testing and pap test market. Based on the availability of data, information related to new products and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.
  1. Report Summary
  • Current Industry Analysis and Growth Potential Outlook
  • Global HPV Testing and Pap Test Market Sales Analysis – Product Type | Technology | End User ($ Million)
  • HPV Testing and Pap Test Market Sales Performance of Top Countries

1.1 Research Methodology

  • Primary Research Approach
  • Secondary Research Approach

1.2 Market Snapshot

  1. Market Overview and Insights

2.1 Scope of the Study

2.2 Analyst Insight & Current Market Trends

2.2.1 Key HPV Testing and Pap Test Market Trends

2.2.2 Market Recommendations

2.3 Porter's Five Forces Analysis for the HPV Testing and Pap Test Market

2.3.1 Competitive Rivalry

2.3.2 Threat of New Entrants

2.3.3 Bargaining Power of Suppliers

2.3.4 Bargaining Power of Buyers

2.3.5 Threat of Substitutes

  1. Market Determinants

3.1 Market Drivers

3.1.1 Drivers For Global HPV Testing and Pap Test Market: Impact Analysis

3.2 Market Pain Points and Challenges

3.2.1 Restraints For Global HPV Testing and Pap Test Market: Impact Analysis

3.3 Market Opportunities

3.3.1 Opportunities For Global HPV Testing and Pap Test Market: Impact Analysis

  1. Competitive Landscape

4.1 Competitive Dashboard – HPV Testing and Pap Test Market Revenue and Share by Manufacturers

  • HPV Testing and Pap Test Product Comparison Analysis
  • Top Market Player Ranking Matrix

4.2 Key Company Analysis

4.2.1 Roche Diagnostics

4.2.1.1 Overview

4.2.1.2 Product Portfolio

4.2.1.3 Financial Analysis

4.2.1.4 SWOT Analysis

4.2.1.5 Business Strategy

4.2.2 Hologic Inc.

4.2.2.1 Overview

4.2.2.2 Product Portfolio

4.2.2.3 Financial Analysis

4.2.2.4 SWOT Analysis

4.2.2.5 Business Strategy

4.2.3 QIAGEN N.V.

4.2.3.1 Overview

4.2.3.2 Product Portfolio

4.2.3.3 Financial Analysis

4.2.3.4 SWOT Analysis

4.2.3.5 Business Strategy

4.2.4 BD (Becton Dickinson)

4.2.4.1 Overview

4.2.4.2 Product Portfolio

4.2.4.3 Financial Analysis

4.2.4.4 SWOT Analysis

4.2.4.5 Business Strategy

4.2.5 Abbott Laboratories

4.2.5.1 Overview

4.2.5.2 Product Portfolio

4.2.5.3 Financial Analysis

4.2.5.4 SWOT Analysis

4.2.5.5 Business Strategy

4.3 Top Winning Strategies by Market Players

4.3.1 Merger and Acquisition

4.3.2 Product Launch

4.3.3 Partnership And Collaboration

  1. Global HPV Testing and Pap Test Market Sales Analysis by Product Type ($ Million)

5.1 Instruments

5.2 Assay Kits & Reagents

5.3 Consumables

  1. Global HPV Testing and Pap Test Market Sales Analysis by Technology ($ Million)

6.1 PCR-based Testing

6.2 Hybrid Capture Technology

6.3 Next-Generation Sequencing

6.4 Other Molecular Methods

  1. Global HPV Testing and Pap Test Market Sales Analysis by End User ($ Million)

7.1 Hospitals

7.2 Diagnostic Laboratories

7.3 Clinics & Gynecology Centers

7.4 Home-care / Self-sampling

  1. Regional Analysis

8.1 North American HPV Testing and Pap Test Market Sales Analysis – Product Type | Technology | End User | Country ($ Million)

8.1.1 United States

8.1.2 Canada

8.2 European HPV Testing and Pap Test Market Sales Analysis – Product Type | Technology | End User | Country ($ Million)

8.2.1 UK

8.2.2 Germany

8.2.3 Italy

8.2.4 Spain

8.2.5 France

8.2.6 Russia

8.2.7 Rest of Europe

8.3 Asia-Pacific HPV Testing and Pap Test Market Sales Analysis – Product Type | Technology | End User | Country ($ Million)

8.3.1 China

8.3.2 Japan

8.3.3 South Korea

8.3.4 India

8.3.5 Australia & New Zealand

8.3.6 ASEAN Countries

8.3.7 Rest of Asia-Pacific

8.4 Rest of the World HPV Testing and Pap Test Market Sales Analysis – Product Type | Technology | End User | Country ($ Million)

8.4.1 Latin America

8.4.2 Middle East and Africa

  1. Company Profiles

9.1 Agilent Technologies (Dako)

9.1.1 Quick Facts

9.1.2 Company Overview

9.1.3 Product Portfolio

9.1.4 Business Strategies

9.2 Artron Laboratories

9.2.1 Quick Facts

9.2.2 Company Overview

9.2.3 Product Portfolio

9.2.4 Business Strategies

9.3 BD (SurePath)

9.3.1 Quick Facts

9.3.2 Company Overview

9.3.3 Product Portfolio

9.3.4 Business Strategies

9.4 BGI Genomics

9.4.1 Quick Facts

9.4.2 Company Overview

9.4.3 Product Portfolio

9.4.4 Business Strategies

9.5 bioMérieux

9.5.1 Quick Facts

9.5.2 Company Overview

9.5.3 Product Portfolio

9.5.4 Business Strategies

9.6 Bio-Rad Laboratories

9.6.1 Quick Facts

9.6.2 Company Overview

9.6.3 Product Portfolio

9.6.4 Business Strategies

9.7 Danaher (Cepheid)

9.7.1 Quick Facts

9.7.2 Company Overview

9.7.3 Product Portfolio

9.7.4 Business Strategies

9.8 DiaSorin S.p.A.

9.8.1 Quick Facts

9.8.2 Company Overview

9.8.3 Product Portfolio

9.8.4 Business Strategies

9.9 Fapon Biotech

9.9.1 Quick Facts

9.9.2 Company Overview

9.9.3 Product Portfolio

9.9.4 Business Strategies

9.10 Fujirebio

9.10.1 Quick Facts

9.10.2 Company Overview

9.10.3 Product Portfolio

9.10.4 Business Strategies

9.11 Genomica (PharmaMar)

9.11.1 Quick Facts

9.11.2 Company Overview

9.11.3 Product Portfolio

9.11.4 Business Strategies

9.12 Hologic (ThinPrep)

9.12.1 Quick Facts

9.12.2 Company Overview

9.12.3 Product Portfolio

9.12.4 Business Strategies

9.13 Hybribio Limited

9.13.1 Quick Facts

9.13.2 Company Overview

9.13.3 Product Portfolio

9.13.4 Business Strategies

9.14 Nihon Kohden

9.14.1 Quick Facts

9.14.2 Company Overview

9.14.3 Product Portfolio

9.14.4 Business Strategies

9.15 Sansure Biotech

9.15.1 Quick Facts

9.15.2 Company Overview

9.15.3 Product Portfolio

9.15.4 Business Strategies

9.16 Seegene Inc.

9.16.1 Quick Facts

9.16.2 Company Overview

9.16.3 Product Portfolio

9.16.4 Business Strategies

9.17 Sysmex Corporation

9.17.1 Quick Facts

9.17.2 Company Overview

9.17.3 Product Portfolio

9.17.4 Business Strategies

9.18 Thermo Fisher Scientific

9.18.1 Quick Facts

9.18.2 Company Overview

9.18.3 Product Portfolio

9.18.4 Business Strategies

9.19 Trivitron Healthcare

9.19.1 Quick Facts

9.19.2 Company Overview

9.19.3 Product Portfolio

9.19.4 Business Strategies

9.20 Zybio Inc.

9.20.1 Quick Facts

9.20.2 Company Overview

9.20.3 Product Portfolio

9.20.4 Business Strategies

1. Global HPV Testing and Pap Test Market Research and Analysis by Product Type, 2026–2035 ($ Million) 

2. Global Instruments HPV Testing and Pap Test Market Research and Analysis by Region, 2026–2035 ($ Million) 

3. Global Assay Kits & Reagents HPV Testing and Pap Test Market Research and Analysis by Region, 2026–2035 ($ Million) 

4. Global Consumables HPV Testing and Pap Test Market Research and Analysis by Region, 2026–2035 ($ Million) 

5. Global HPV Testing and Pap Test Market Research and Analysis by Technology, 2026–2035 ($ Million) 

6. Global PCR-based Testing HPV Testing and Pap Test Market Research and Analysis by Region, 2026–2035 ($ Million) 

7. Global Hybrid Capture Technology HPV Testing and Pap Test Market Research and Analysis by Region, 2026–2035 ($ Million) 

8. Global Next-Generation Sequencing HPV Testing and Pap Test Market Research and Analysis by Region, 2026–2035 ($ Million) 

9. Global Other Molecular Methods HPV Testing and Pap Test Market Research and Analysis by Region, 2026–2035 ($ Million) 

10. Global HPV Testing and Pap Test Market Research and Analysis by End User, 2026–2035 ($ Million) 

11. Global HPV Testing and Pap Test for Hospitals Market Research and Analysis by Region, 2026–2035 ($ Million) 

12. Global HPV Testing and Pap Test  for Diagnostic Laboratories Market Research and Analysis by Region, 2026–2035 ($ Million) 

13. Global HPV Testing and Pap Test for Clinics & Gynecology Centers Market Research and Analysis by Region, 2026–2035 ($ Million) 

14. Global HPV Testing and Pap Test for Home-care / Self-sampling Market Research and Analysis by Region, 2026–2035 ($ Million) 

15. Global HPV Testing and Pap Test Market Research and Analysis by Region, 2026–2035 ($ Million) 

16. North America HPV Testing and Pap Test Market Research and Analysis by Country, 2026–2035 ($ Million) 

17. North America HPV Testing and Pap Test Market Research and Analysis by Product Type, 2026–2035 ($ Million) 

18. North America HPV Testing and Pap Test Market Research and Analysis by Technology, 2026–2035 ($ Million) 

19. North America HPV Testing and Pap Test Market Research and Analysis by End User, 2026–2035 ($ Million) 

20. Europe HPV Testing and Pap Test Market Research and Analysis by Country, 2026–2035 ($ Million) 

21. Europe HPV Testing and Pap Test Market Research and Analysis by Product Type, 2026–2035 ($ Million) 

22. Europe HPV Testing and Pap Test Market Research and Analysis by Technology, 2026–2035 ($ Million) 

23. Europe HPV Testing and Pap Test Market Research and Analysis by End User, 2026–2035 ($ Million) 

24. Asia-Pacific HPV Testing and Pap Test Market Research and Analysis by Country, 2026–2035 ($ Million) 

25. Asia-Pacific HPV Testing and Pap Test Market Research and Analysis by Product Type, 2026–2035 ($ Million) 

26. Asia-Pacific HPV Testing and Pap Test Market Research and Analysis by Technology, 2026–2035 ($ Million) 

27. Asia-Pacific HPV Testing and Pap Test Market Research and Analysis by End User, 2026–2035 ($ Million) 

28. Rest of the World HPV Testing and Pap Test Market Research and Analysis by Region, 2026–2035 ($ Million) 

29. Rest of the World HPV Testing and Pap Test Market Research and Analysis by Product Type, 2026–2035 ($ Million) 

30. Rest of the World HPV Testing and Pap Test Market Research and Analysis by Technology, 2026–2035 ($ Million) 

31. Rest of the World HPV Testing and Pap Test Market Research and Analysis by End User, 2026–2035 ($ Million) 

32. Global HPV Testing and Pap Test Market – Top 5 Companies Market Share Analysis, 2026 (%) 

33. Global HPV Testing and Pap Test Market – Top 5 Companies Revenue Comparison, 2026–2035 ($ Million) 

1. Global HPV Testing and Pap Test Market Share by Product Type, 2026 Vs 2035 (%) 

2. Global Instruments HPV Testing and Pap Test Market Research and Analysis by Region, 2026 Vs 2035 (%) 

3. Global Assay Kits & Reagents HPV Testing and Pap Test Market Research and Analysis by Region, 2026 Vs 2035 (%) 

4. Global Consumables HPV Testing and Pap Test Market Research and Analysis by Region, 2026 Vs 2035 (%) 

5. Global HPV Testing and Pap Test Market Share by Technology, 2026 Vs 2035 (%) 

6. Global PCR-based Testing HPV Testing and Pap Test Market Research and Analysis by Region, 2026 Vs 2035 (%) 

7. Global Hybrid Capture Technology HPV Testing and Pap Test Market Research and Analysis by Region, 2026 Vs 2035 (%) 

8. Global Next-Generation Sequencing HPV Testing and Pap Test Market Research and Analysis by Region, 2026 Vs 2035 (%) 

9. Global Other Molecular Methods HPV Testing and Pap Test Market Research and Analysis by Region, 2026 Vs 2035 (%) 

10. Global HPV Testing and Pap Test Market Share by End User, 2026 Vs 2035 (%) 

11. Global HPV Testing and Pap Test for Hospitals Market Research and Analysis by Region, 2026 Vs 2035 (%) 

12. Global HPV Testing and Pap Test for Diagnostic Laboratories Market Research and Analysis by Region, 2026 Vs 2035 (%) 

13. Global HPV Testing and Pap Test for Clinics & Gynecology Centers Market Research and Analysis by Region, 2026 Vs 2035 (%) 

14. Global HPV Testing and Pap Test for Home-care / Self-sampling Market Research and Analysis by Region, 2026 Vs 2035 (%) 

15. Global HPV Testing and Pap Test Market Share by Region, 2026 Vs 2035 (%) 

16. U.S. HPV Testing and Pap Test Market Size, 2026–2035 ($ Million) 

17. Canada HPV Testing and Pap Test Market Size, 2026–2035 ($ Million) 

18. UK HPV Testing and Pap Test Market Size, 2026–2035 ($ Million) 

19. France HPV Testing and Pap Test Market Size, 2026–2035 ($ Million) 

20. Germany HPV Testing and Pap Test Market Size, 2026–2035 ($ Million) 

21. Italy HPV Testing and Pap Test Market Size, 2026–2035 ($ Million) 

22. Spain HPV Testing and Pap Test Market Size, 2026–2035 ($ Million) 

23. Russia HPV Testing and Pap Test Market Size, 2026–2035 ($ Million) 

24. India HPV Testing and Pap Test Market Size, 2026–2035 ($ Million) 

25. China HPV Testing and Pap Test Market Size, 2026–2035 ($ Million) 

26. Japan HPV Testing and Pap Test Market Size, 2026–2035 ($ Million) 

27. South Korea HPV Testing and Pap Test Market Size, 2026–2035 ($ Million) 

28. Australia & New Zealand HPV Testing and Pap Test Market Size, 2026–2035 ($ Million) 

29. ASEAN HPV Testing and Pap Test Market Size, 2026–2035 ($ Million) 

30. Rest of Asia-Pacific HPV Testing and Pap Test Market Size, 2026–2035 ($ Million) 

31. Latin America HPV Testing and Pap Test Market Size, 2026–2035 ($ Million) 

32. Middle East & Africa HPV Testing and Pap Test Market Size, 2026–2035 ($ Million)

Choose License Type
    On Discount
Enterprise Custom
  • Printable version
  • No restriction to number of users within the company
CONTACT SALES

100%
Secured Payment

Why buy from us?
  • Covers more than 15 major industries, which are further segmented into 90+ sectors
  • 65% of our clients are loyal customers
  • 120+ countries are covered in analysis
  • currently servicing 1000+ customers globally
  • 100+ paid data sources mined to research
  • Our expert team will assist you with all research need and customization
  • Our expert research analyst will resolve your every query before and after purchasing the report
Related Reports

FAQS

The market was valued at $2.8 billion in 2025 and is projected to reach $7.4 billion by 2035.
The market is expected to grow at a CAGR of 10.2% during 2026–2035.
The Assay Kits & Reagents segment dominates due to high recurring demand and widespread use in diagnostics.
North America, particularly the United States, leads due to strong healthcare infrastructure and screening programs.
PCR-based testing is the fastest-growing segment due to its high accuracy and early detection capabilities.